|
1-N,3-N-dimethyl-5-[4-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]benzene-1,3-dicarboxamide |
|
Escherichia |
Type 1 fimbriae |
Preclinical (in vitro) |
Han Z, et al. 2010. J Med Chem |
|
Bio8B6 |
Depiction based on curated SMILES
HO
Cl
Cl
H
3
C
N
Cl
O
|
Escherichia |
TTSS (Type III secretion system) |
Preclinical (in vitro) |
Gauthier A, et al. 2005. Antimicrob Agents Chemother |
|
3-[4-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-N-[2-[2-[2-[[3-[4-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]benzoyl]amino]ethoxy]ethoxy]ethyl]benzamide |
Depiction based on curated SMILES
OH
OH
OH
OH
O
H
H
H
H
OH
OH
OH
OH
O
H
H
H
H
H
O
N
H
O
O
HN
O
H
O
O
|
Escherichia |
Type 1 fimbriae |
Preclinical (in vitro) |
Han Z, et al. 2010. J Med Chem |
|
dimethyl 5-[4-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]benzene-1,3-dicarboxylate |
Depiction based on curated SMILES
H
H
H
H
O
H
HO
HO
HO
OH
O
O
CH
3
O
O
CH
3
O
|
Escherichia |
Type 1 fimbriae |
Preclinical (in vitro) |
Han Z, et al. 2010. J Med Chem |
|
methyl 3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybenzoate |
Depiction based on curated SMILES
OH
OH
HO
HO
H
3
C
O
O
O
O
|
Escherichia |
Type 1 fimbriae |
Preclinical (in vitro) |
Cusumano CK, et al. 2011. Sci Transl Med |
|
methyl 3-[4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]benzoate |
Depiction based on curated SMILES
OH
OH
HO
HO
H
3
C
O
O
O
O
|
Escherichia |
Type 1 fimbriae |
Preclinical (in vitro) |
Cusumano CK, et al. 2011. Sci Transl Med |
|
N-methyl-3-[4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]benzamide |
Depiction based on curated SMILES
OH
OH
HO
HO
H
3
C
O
O
O
NH
|
Escherichia |
Type 1 fimbriae |
Preclinical (in vitro) |
Cusumano CK, et al. 2011. Sci Transl Med |
|
1-(3,4-dichlorophenyl)-2-[2-imino-3-(2-piperidin-1-ium-1-ylethyl)benzimidazol-1-yl]ethanone |
Depiction based on curated SMILES
Cl
Cl
O
HN
N
N
H
+
N
|
Mycobacterium |
Motility |
Preclinical (in vitro) |
Ouertatani-Sakouhi H, et al. 2017. PLoS One |
|
3-(3,5-DIBROMO-4-HYDROXY-BENZOYL)-2-ETHYL-BENZOFURAN-6-SULFONIC ACID [4-(THIAZOL-2-YLSULFAMOYL)-PHENYL]-AMIDE |
Depiction based on curated SMILES
O
S
O
O
NH
N
S
Br
OH
Br
O
CH
3
S
O
O
NH
|
Mycobacterium |
Exoenzyme |
Preclinical (in vitro) |
Beresford NJ, et al. 2009. J Antimicrob Chemother |
|
3-((S)-2-(3-benzoyl-1-cyanoindolizin-5-yloxy)-4-methylpentanamido)-3-phenylpropanoic acid |
Depiction based on curated SMILES
N
O
O
N
CH
3
H
O
N
H
H
3
C
O
OH
|
Mycobacterium |
Exoenzyme |
Preclinical (in vitro) |
Weide T, et al. 2006. Bioorg Med Chem Lett |
|
| | |